Question reference: S6W-00918
- Asked by: Jackson Carlaw, MSP for Eastwood, Scottish Conservative and Unionist Party
- Date lodged: 21 June 2021
-
Current status: Answered by Humza Yousaf on 22 July 2021
Question
To ask the Scottish Government what communication it has had with the (a) UK Government and (b) Medicines and Healthcare products Regulatory Agency (MHRA) regarding the possible future use of the drug, ivermectin, to treat COVID-19 patients.
Answer
The Scottish Government’s office of the Chief Medical Officer is working closely with the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency (MHRA) to prioritise potential treatments for COVID-19. Further results of well-designed randomised controlled clinical trials exploring treatment efficacy of ivermectin to treat COVID-19 are awaited.
The MHRA, together with an independent advisory group, continues to review the emerging body of evidence regarding potential medicines for treatment or prevention of COVID-19, including Ivermectin.
The MHRA advises that, at this time, no application has been received for a licence for ivermectin in the treatment of COVID-19, in the UK. However, should an application for a licence be made, then the MHRA has processes in place to expedite such an application, as required.